NEW YORK (GenomeWeb News) – The US Food and Drug Administration has approved a hepatitis C viral load assay made by Siemens Healthcare that can help physicians to monitor the disease, the company said today.
Siemens said its Versant 440 Molecular System was approved for marketing and for use with the company’s Versant HCV RNA 3.0 assay for management of HCV-infected patients.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

An opinion piece in the Guardian argues that President Donald Trump is uninterested in science and that might not be a bad thing for the field.

The San Francisco Chronicle reports the Veterans Affairs Health System is studying whether genetic testing can help prescribe better depression therapies.

Stat News reports that Spark Therapeutics' Luxturna is now being used to treat a wider array of patients.

In Genome Biology this week: transcription factor use among brittle stars, single-cell RNA sequencing strategy, and more.